FASN and ovarian carcinoma: First, we confirmed and extended our earlier observations [7] and others [6,14,28] of considerable FASN overexpression in human ovarian cancer cells relative to that in healthy human tissue with a tendency towards higher expression in more aggressive, de-differentiated tumors.